1986
DOI: 10.1016/0277-5379(86)90139-2
|View full text |Cite
|
Sign up to set email alerts
|

Hodgkin's disease (HD): A historical perspective

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1988
1988
2004
2004

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(2 citation statements)
references
References 32 publications
0
2
0
Order By: Relevance
“…Since this time, the department has developed into a preferred primary care centre for patients with established or suspected chronic lymphocytic leukemia for a population of approximately 1 million people. Patients are treated according to the relevant international standard procedures, with staging and treatment strategies being continuously adapted to changing standards (26). Before 1994, first line chemotherapy consisted of alkylans‐based treatment, usually administered intravenously via a CVP line, or oral chlorambucil with or without prednisone.…”
Section: Methodsmentioning
confidence: 99%
“…Since this time, the department has developed into a preferred primary care centre for patients with established or suspected chronic lymphocytic leukemia for a population of approximately 1 million people. Patients are treated according to the relevant international standard procedures, with staging and treatment strategies being continuously adapted to changing standards (26). Before 1994, first line chemotherapy consisted of alkylans‐based treatment, usually administered intravenously via a CVP line, or oral chlorambucil with or without prednisone.…”
Section: Methodsmentioning
confidence: 99%
“…Patients are treated according to the relevant internationally recognized standard procedures, with staging and treatment strategies being continuously adapted to changing criteria (8). Since July 1988, it has been the policy of the hospital to include all consenting patients in international, randomized, phase III clinical trials of the German Hodgkin Study Group (GHSG; 7, 9–11).…”
Section: Samplementioning
confidence: 99%